How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via LESIC AND CAMPER COMMUNICATIONS
2026 · third_quarter · Q3
Healthcare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via LESIC AND CAMPER COMMUNICATIONS
2026 · second_quarter · Q2
Source: Senate LDA
Healthcare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via LESIC AND CAMPER COMMUNICATIONS
2026 · first_quarter · Q1
Healthcare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via LESIC AND CAMPER COMMUNICATIONS
2025 · fourth_quarter · Q4
Healthcare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via LESIC AND CAMPER COMMUNICATIONS
2025 · third_quarter · Q3
Healthcare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via LESIC AND CAMPER COMMUNICATIONS
2025 · second_quarter · Q2
Healthcare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via LESIC AND CAMPER COMMUNICATIONS
2025 · first_quarter · Q1
Healthcare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via LESIC AND CAMPER COMMUNICATIONS
2024 · fourth_quarter · Q4
Health care access
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via LESIC AND CAMPER COMMUNICATIONS
2024 · third_quarter · Q3
Health care access
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via LESIC AND CAMPER COMMUNICATIONS
2024 · second_quarter · Q2
Health care access
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via LESIC AND CAMPER COMMUNICATIONS
2024 · first_quarter · Q1
Medicare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via LESIC AND CAMPER COMMUNICATIONS
2023 · fourth_quarter · Q4
Medicare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via LESIC AND CAMPER COMMUNICATIONS
2023 · third_quarter · Q3
Medicare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via LESIC AND CAMPER COMMUNICATIONS
2023 · second_quarter · Q2
Medicare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via LESIC AND CAMPER COMMUNICATIONS
2023 · first_quarter · Q1
Medicare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via LESIC AND CAMPER COMMUNICATIONS
2022 · fourth_quarter · Q4
Medicare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via LESIC AND CAMPER COMMUNICATIONS
2022 · third_quarter · Q3
Medicare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via LESIC AND CAMPER COMMUNICATIONS
2022 · second_quarter · Q2
Medicare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via LESIC AND CAMPER COMMUNICATIONS
2022 · first_quarter · Q1
Medicare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via LESIC AND CAMPER COMMUNICATIONS
2021 · fourth_quarter · Q4
Medicare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via LESIC AND CAMPER COMMUNICATIONS
2021 · third_quarter · Q3
Medicare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via LESIC AND CAMPER COMMUNICATIONS
2021 · second_quarter · Q2
Medicare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via LESIC AND CAMPER COMMUNICATIONS
2021 · first_quarter · Q1
Medicare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via LESIC AND CAMPER COMMUNICATIONS
2020 · fourth_quarter · Q4
Medicare Part D
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via LESIC AND CAMPER COMMUNICATIONS
2020 · third_quarter · Q3
Medicare Part D
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via LESIC AND CAMPER COMMUNICATIONS
2020 · second_quarter · Q2
Medicare Part D
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via LESIC AND CAMPER COMMUNICATIONS
2020 · first_quarter · Q1
Medicare Part D
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via LESIC AND CAMPER COMMUNICATIONS
2019 · fourth_quarter · Q4
Medicare Part D
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via LESIC AND CAMPER COMMUNICATIONS
2019 · third_quarter · Q3
Medicare Part D
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via LESIC AND CAMPER COMMUNICATIONS
2019 · second_quarter · Q2
Medicare Part D
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via LESIC AND CAMPER COMMUNICATIONS
2019 · first_quarter · Q1
Medicare Part D
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via LESIC AND CAMPER COMMUNICATIONS
2018 · fourth_quarter · Q4
Medicare Part D
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via LESIC AND CAMPER COMMUNICATIONS
2018 · third_quarter · Q3
Medicare Part D
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via LESIC AND CAMPER COMMUNICATIONS
2018 · second_quarter · Q2
Medicare Part D
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via LESIC AND CAMPER COMMUNICATIONS
2018 · first_quarter · Q1
Medicare Part D
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via LESIC AND CAMPER COMMUNICATIONS
2017 · fourth_quarter · Q4
Medicare Part D
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via LESIC AND CAMPER COMMUNICATIONS
2017 · third_quarter · Q3
Medicare Part D
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via LESIC AND CAMPER COMMUNICATIONS
2017 · second_quarter · Q2
Medicare Part D
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via LESIC AND CAMPER COMMUNICATIONS
2017 · first_quarter · Q1
Medicare Part D
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via LESIC AND CAMPER COMMUNICATIONS
2016 · fourth_quarter · Q4
Medicare Part D
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via LESIC AND CAMPER COMMUNICATIONS
2016 · third_quarter · Q3
Medicare Part D
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via LESIC AND CAMPER COMMUNICATIONS
2016 · second_quarter · Q2
Medicare Part D
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via LESIC AND CAMPER COMMUNICATIONS
2016 · first_quarter · Q1
Medicare Part D
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via LESIC AND CAMPER COMMUNICATIONS
2015 · fourth_quarter · Q4
Medicare Part D
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via LESIC AND CAMPER COMMUNICATIONS
2015 · third_quarter · Q3
Medicare Part D
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via LESIC AND CAMPER COMMUNICATIONS
2015 · second_quarter · Q2
Medicare Part D
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via LESIC AND CAMPER COMMUNICATIONS
2015 · first_quarter · Q1
Medicare Part D
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via LESIC AND CAMPER COMMUNICATIONS
2014 · fourth_quarter · Q4
Medicare Part D
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via LESIC AND CAMPER COMMUNICATIONS
2014 · third_quarter · Q3
Medicare Part D
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via LESIC AND CAMPER COMMUNICATIONS
2014 · second_quarter · Q2
Medicare Part D
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via LESIC AND CAMPER COMMUNICATIONS
2014 · first_quarter · Q1
Medicare Part D
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via LESIC AND CAMPER COMMUNICATIONS
2013 · fourth_quarter · Q4
Medicare Part D
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via LESIC AND CAMPER COMMUNICATIONS
2013 · third_quarter · Q3
Medicare Part D
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via LESIC AND CAMPER COMMUNICATIONS
2013 · second_quarter · Q2
Medicare Part D
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via LESIC AND CAMPER COMMUNICATIONS
2013 · first_quarter · 1A
Medicare Part Dhttp://www.phrma.org/about_phrma/member_company_list/members/
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via LESIC AND CAMPER COMMUNICATIONS
2013 · first_quarter · Q1
Medicare Part Dhttp://www.phrma.org/about_phrma/member_company_list/members/
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via LESIC AND CAMPER COMMUNICATIONS
2012 · fourth_quarter · Q4
Medicare Part D program for seniors
Filing targets: SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via LESIC AND CAMPER COMMUNICATIONS
2012 · second_quarter · Q2
None
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via LESIC AND CAMPER COMMUNICATIONS
2011 · fourth_quarter · Q4
Medicare Part D as part of budget deficit reduction discussions http://www.phrma.org/about_phrma/member_company_list/members/
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via LESIC AND CAMPER COMMUNICATIONS
2011 · third_quarter · Q3
Medicare Part D program as part of budget deficit reduction discussions
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via LESIC AND CAMPER COMMUNICATIONS
2011 · second_quarter · RA
Medicare Part D issues in the federal budget, IPAB
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via LESIC AND CAMPER COMMUNICATIONS
2011 · second_quarter · 2A
Affordable Care Act, Medicare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via LESIC AND CAMPER COMMUNICATIONS
2011 · second_quarter · 2A
Affordable Care Act, Medicare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via LESIC AND CAMPER COMMUNICATIONS
2011 · second_quarter · Q2
health issues, Medicare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via LESIC AND CAMPER COMMUNICATIONS
2009 · fourth_quarter · 4T
Promotion of chronic disease prevention and treatment incentives in healthcare reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via LESIC AND CAMPER COMMUNICATIONS
2009 · third_quarter · Q3
Promotion of chronic disease prevention and treatment incentives in healthcare reform. House Tri-Committee Health Senate Finance Committee options papers "America's Healthy Futures Act of 2009"
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via LESIC AND CAMPER COMMUNICATIONS
2009 · second_quarter · Q2
Promotion of chronic disease prevention and treatment incentives in healthcare reform. House Tri-Committee Health Reform Discussion Draft Senate Finance Committee options papers
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via LESIC AND CAMPER COMMUNICATIONS
2009 · second_quarter · RR
Promotion of chronic disease prevention and treatment incentives in healthcare reform.